Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

mouse brain in stereotaxic coordinates

Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476

Antipsychotic drug doses and neuroleptic/dopamine receptors

SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372

Molecular diversity of the NMDA receptor channel

Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352

HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells

Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086

Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder

Palomino, A., González-Pinto, A. M., Aldama, A., González-Gómez, C., Mosquera, F., González-García, G., & Matute, C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.012 · Cited by 71

Significant Association Between the Genetic Variations in the 5′ End of the N-Methyl-D-Aspartate Receptor Subunit Gene GRIN1 and Schizophrenia

Zhao, X., Li, H., Shi, Y., Tang, R., Chen, W., Liu, J., Feng, G., Shi, J., Yan, L., Liu, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.023 · Cited by 70

Human gestational N‐methyl‐d‐aspartate receptor autoantibodies impair neonatal murine brain function

Jurek, B., Chayka, M., Kreye, J., Lang, K., Kraus, L., Fidzinski, P., Kornau, H.-C., Dao, L.-M., Wenke, N., Long, M., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25552 · Cited by 59

Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia

Dogra, S., & Conn, P. J. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.121.000460 · Cited by 70

Mutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia

O’Tuathaigh, C. M. P., Kirby, B. P., Moran, P. M., & Waddington, J. L. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp125 · Cited by 73

Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system

van Coevorden‐Hameete, M. H., de Graaff, E., Titulaer, M. J., Hoogenraad, C. C., & Smitt, P. A. E. S. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.016 · Cited by 71

GABAA receptor γ2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines

Chandra, D., Korpi, E., Miralles, C., Blas, A. D., & Homanics, G. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-30 · Cited by 71

Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia

Sullivan, C. R., Mielnik, C. A., Funk, A., O'Donovan, S. M., Bentea, E., Pletnikov, M. V., Ramsey, A. J., Wen, Z., Rowland, L. M., & McCullumsmith, R. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-41572-9 · Cited by 69

Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism

Moy, S. S., Riddick, N. V., Nikolova, V. D., Teng, B. L., Agster, K. L., Nonneman, R. J., Young, N. B., Baker, L. K., Nadler, J. J., & Bodfish, J. W. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.052 · Cited by 71

Animal Models of Psychosis: Current State and Future Directions

Forrest, A. D., Coto, C. A., & Siegel, S. J. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0013-2 · Cited by 69

A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk

Sydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 68

Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation

Carboni, G., Tueting, P. A., Tremolizzo, L., Sugaya, I., Davis, J. M., Costa, E., & Guidotti, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.001 · Cited by 68

Toward recovery in schizophrenia: Current concepts, findings, and future research directions

Onitsuka, T., Hirano, Y., Nakazawa, T., Ichihashi, K., Miura, K., Inada, K., Mitoma, R., Yasui‐Furukori, N., & Hashimoto, R. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13342 · Cited by 76

Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review

Inta, D., Monyer, H., Sprengel, R., Meyer‐Lindenberg, A., & Gass, P. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.010 · Cited by 67

Hypomorphic Apolipoprotein E Mice

Raffaı̈, R. L., & Weisgraber, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111222200 · Cited by 67

Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate☆

Bickel, S., & Javitt, D. C. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.005 · Cited by 68

Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia

Banerjee, A., Wang, H.-Y., Borgmann‐Winter, K. E., MacDonald, M. L., Kaprielian, H., Stucky, A., Kvasic, J., Egbujo, C. N., Ray, R., Talbot, K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.115 · Cited by 65

Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor

Savonenko, A., Muñoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R., Montine, T., Kirkwood, A., & Andreasson, K. I. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 70

The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy

Yadav, P. N., Abbas, A. I., Farrell, M. S., Setola, V., Sciaky, N., Huang, X., Kroeze, W. K., Crawford, L. K., Piel, D., Keiser, M. J., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.195 · Cited by 65

Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs

Fumagalli, F., Frasca, A., Racagni, G., & Riva, M. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043786 · Cited by 66

NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique

Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 69

Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5

Burrows, E. L., McOmish, C. E., Buret, L., van den Buuse, M., & Hannan, A. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.44 · Cited by 65

Expression of Mutant NMDA Receptors in Dopamine D1Receptor-Containing Cells Prevents Cocaine Sensitization and Decreases Cocaine Preference

Heusner, C. L., & Palmiter, R. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1474-05.2005 · Cited by 65

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia

Frånberg, O., Wiker, C., Marcus, M. M., Konradsson‐Geuken, Å., Jardemark, K. E., Schilström, B., Shahid, M., Wong, E. H. F., & Svensson, T. H. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0973-y · Cited by 65

GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia

Sapkota, K., Mao, Z., Synowicki, P., Lieber, D., Liu, M., Ikezu, T., Gautam, V., & Monaghan, D. T. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230391 · Cited by 66

Neurodevelopmental Role for VGLUT2 in Pyramidal Neuron Plasticity, Dendritic Refinement, and in Spatial Learning

He, H., Mahnke, A. H., Doyle, S., Fan, N., Wang, C.-C., Hall, B. J., Tang, Y., Inglis, F. M., Chen, C., & Erickson, J. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4505-11.2012 · Cited by 67

Attention-Deficit/Hyperactivity Disorder–like Phenotype in a Mouse Model with Impaired Actin Dynamics

Zimmermann, A.-M., Jene, T., Wolf, M., Görlich, A., Gurniak, C. B., Sassoé‐Pognetto, M., Witke, W., Friauf, E., & Rust, M. B. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.03.011 · Cited by 63

Long-term regulation of n-methyl-d-aspartate receptor subunits and associated synaptic proteins following hippocampal synaptic plasticity

Williams, J. M., Guévremont, D., Kennard, J. T., Mason‐Parker, S. E., Tate, W. P., & Abraham, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00028-9 · Cited by 65

Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.

Moy, S., Perez, A., Koller, B., & Duncan, G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.073 · Cited by 65

Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function

Bickel, S., Lipp, H., & Umbricht, D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301536 · Cited by 61

Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801

Hashimoto, A., Yoshikawa, M., Niwa, A., & Konno, R. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.031 · Cited by 61

Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders

Virdee, K., Cumming, P. D., Caprioli, D., Jupp, B., Rominger, A., Aigbirhio, F. I., Fryer, T. D., Riss, P. J., & Dalley, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.009 · Cited by 61

Translational value of startle modulations

Fendt, M., & Koch, M. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1599-5 · Cited by 63

Reversal of social deficits by subchronic oxytocin in two autism mouse models

Teng, B. L., Nikolova, V. D., Riddick, N. V., Agster, K. L., Crowley, J. J., Baker, L. K., Koller, B. H., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.025 · Cited by 65

Mouse Genetic Models of Human Brain Disorders

Leung, C., & Jia, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00040 · Cited by 63

Mutation screening of the Homer gene family and association analysis in schizophrenia

Norton, N., Williams, H. J., Williams, N. M., Spurlock, G., Zammit, S., Jones, G., Jones, S., Owen, R., O’Donovan, M. C., & Owen, M. J. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20032 · Cited by 61

Profiling of mouse synaptosome proteome and phosphoproteome by IEF

Filiou, M. D., Bisle, B., Reckow, S., Teplytska, L., Maccarrone, G., & Turck, C. W. (2010) · Electrophoresis · doi:10.1002/elps.200900647 · Cited by 59

Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice

Foote, M. M., Qiao, H., Graham, K., Wu, Y., & Zhou, Y. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.015 · Cited by 60

Potential Role for Astroglial d-Amino Acid Oxidase in Extracellular d-Serine Metabolism and Cytotoxicity

Park, H. K., Shishido, Y., Ichise-Shishido, S., Kawazoe, T., Ono, K., Iwana, S., Tomita, Y., Yorita, K., Sakai, T., & Fukui, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj036 · Cited by 60

Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia

Chaki, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.041 · Cited by 60

Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development

Möller, M., Swanepoel, T., & Harvey, B. H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003368 · Cited by 60

An evolving redefinition of autoimmune encephalitis

Esposito, S., Principi, N., Calabresi, P., & Rigante, D. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.08.009 · Cited by 59

N-Methyl-d-aspartate Receptors Regulate a Group of Transiently Expressed Genes in the Developing Brain

Sugiura, N., Patel, R. G., & Corriveau, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100011200 · Cited by 59

Cytokines and Bone Remodeling

Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 59

Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign

Glatt, C. E., & Freimer, N. B. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02670-7 · Cited by 59

Chronic in vivo multi-circuit neurophysiological recordings in mice

Dzirasa, K., Fuentes, R., Kumar, S., Potes, J. M., & Nicolelis, M. A. L. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.11.014 · Cited by 59

The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases

Sánchez‐Blázquez, P., Rodríguez-Muñoz, M., Herrero-Labrador, R., Burgueño, J., Zamanillo, D., & Garzón, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000029 · Cited by 57

Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia

Spangaro, M., Bosia, M., Zanoletti, A., Bechi, M., Cocchi, F., Pirovano, A., Lorenzi, C., Bramanti, P., Benedetti, F., Smeraldi, E., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.030 · Cited by 57

Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?

Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.001 · Cited by 57

Dysbindin-1 and Its Protein Family

Talbot, K., Ong, W., Blake, D. J., Tang, J., Louneva, N., Carlson, G. C., & Arnold, S. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_5 · Cited by 57

NMDA Receptor ActivityIn UteroAverts Respiratory Depression and Anomalous Long-Term Depression in Newborn Mice

Poon, C., Zhou, Z., & Champagnat, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-j0003.2000 · Cited by 57

Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review

Watis, L., Chen, S. H., Chua, H.-C., Chong, S. A., & Sim, K. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0859-5 · Cited by 56

Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function

Duncan, G. E., Miyamoto, S., Gu, H., Lieberman, J. A., Koller, B. H., & Snouwaert, J. N. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03156-6 · Cited by 56

Mutant models for genes associated with schizophrenia

Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370308 · Cited by 57

Diverse Effects on M 1 Signaling and Adverse Effect Liability within a Series of M 1 Ago-PAMs

Rook, J. M., Abe, M., Cho, H. P., Nance, K. D., Luscombe, V. B., Adams, J. J., Dickerson, J. W., Remke, D. H., García-Barrantes, P. M., Engers, D. W., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00429 · Cited by 56

Differential effects of atypical and typical antipsychotic drugs on N‐methyl‐D‐aspartate‐ and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex

Ninan, I., Jardemark, K. E., & Wang, R. Y. (2003) · Synapse · doi:10.1002/syn.10189 · Cited by 56

Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice

Moy, S. S., Nonneman, R. J., Shafer, G. O., Nikolova, V. D., Riddick, N. V., Agster, K. L., Baker, L. K., & Knapp, D. J. (2012) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.007 · Cited by 60

Could Stress Cause Psychosis in Individuals Vulnerable to Schizophrenia?

Corcoran, C. M., Mujica-Parodi, L. R., Yale, S. A., Leitman, D., & Malaspina, D. (2002) · CNS Spectrums · doi:10.1017/s1092852900022240 · Cited by 57

Comparative analysis of the anxiety-related behaviors in four inbred mice

Kim, S., Lee, S., Ryu, S., Suk, J.-G., & Park, C. (2002) · Behavioural Processes · doi:10.1016/s0376-6357(02)00085-2 · Cited by 55

Chronic neonatal N-methyl-d-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats

Latysheva, N. V., & Rayevsky, K. S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00110-6 · Cited by 55

Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors

Todd, P. K., Malter, J. S., & Mack, K. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00657-5 · Cited by 56

Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies

Ramaekers, V. T., Thöny, B., Sequeira, J. M., Ansseau, M., Philippe, P., Boemer, F., Bours, V., & Quadros, E. V. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.10.002 · Cited by 54

Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-D-aspartate currents by dopamine D1 receptor activation in striatum

Jocoy, E. L. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00028 · Cited by 54

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia

de Bartolomeis, A., Manchia, M., Marmo, F., Vellucci, L., Iasevoli, F., & Barone, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00369 · Cited by 54

Consequences of NMDA Receptor Deficiency Can Be Rescued in the Adult Brain

Mielnik, C. A., Binko, M. A., Chen, Y., Funk, A. J., Johansson, E. M., Intson, K., Sivananthan, N., Islam, R., Milenkovic, M., Horsfall, W., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-020-00859-4 · Cited by 56

[Glutamatergic hypothesis of schizophrenia].

Bressan, R., & Pilowsky, L. (2003) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462003000300011 · Cited by 67

Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function

Wallén-Mackenzie, Å., Nordenankar, K., Fejgin, K., Lagerström, M., Emilsson, L., Fredriksson, R., Wass, C., Andersson, D., Egecioglu, E., Andersson, M., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5851-08.2009 · Cited by 54

Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases

Li, S. H., Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108275 · Cited by 53

Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats

Murray, F., Harrison, N. J., Grimwood, S., Bristow, L. J., & Hutson, P. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.027 · Cited by 53

Genetic NMDA Receptor Deficiency Disrupts Acute and Chronic Effects of Cocaine but not Amphetamine

Ramsey, A. J., Laakso, A., Cyr, M., Sotnikova, T. D., Salahpour, A., Medvedev, I. O., Dykstra, L., Gainetdinov, R. R., & Caron, M. G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301663 · Cited by 53

T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice

Matsuda, S., Baba, R., Oki, H., Morimoto, S., Toyofuku, M., Igaki, S., Kamada, Y., Iwasaki, S., Matsumiya, K., Hibino, R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0300-9 · Cited by 53

Potential pathophysiological role of d-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain

Ono, K., Shishido, Y., Park, H. K., Kawazoe, T., Iwana, S., Chung, S. P., El-Magd, R. M. A., Yorita, K., Okano, M., Watanabe, T., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0289-7 · Cited by 53

Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study

Gemperle, A. Y., Enz, A., Pozza, M. F., L�thi, A., & Olpe, H. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00769-8 · Cited by 54

Association of the gene encoding neurogranin with schizophrenia in males

Ruano, D., Aulchenko, Y. S., Macedo, A., Soares, M. J., Valente, J., Azevedo, M. H., Hutz, M. H., Gama, C. S., Lobato, M. I. R., Belmonte-de-Abreu, P. S., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.008 · Cited by 52

Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia

Sodhi, M., Simmons, M. S., McCullumsmith, R. E., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.022 · Cited by 52

Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors

Yuan, A., Veeranna, Sershen, H. W., Basavarajappa, B. S., Smiley, J. F., Hashim, A., Bleiwas, C., Berg, M. J., Guifoyle, D. N., Subbanna, S., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0194-7 · Cited by 54

Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era

Marino, M. J., Knutsen, L. J. S., & Williams, M. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701094q · Cited by 52

Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies

Eltokhi, A., Santuy, A., Merchán-Pérez, Á., & Sprengel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010059 · Cited by 54

Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypes

Niemann, S., Kanki, H., Fukui, Y., Takao, K., Fukaya, M., Hynynen, M., Churchill, M., Shefner, J. M., Bronson, R. T., Brown, R. H., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05774.x · Cited by 52

Regulation of Brain Proteolytic Activity Is Necessary for theIn VivoFunction of NMDA Receptors

Kvajo, M., Albrecht, H., Meins, M., Hengst, U., Troncoso, E., Lefort, S., Kiss, J. Z., Petersen, C. C. H., & Monard, D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3306-04.2004 · Cited by 51

TheNPAS3gene—emerging evidence for a role in psychiatric illness

Pickard, B. S., Pieper, A. A., Porteous, D. J., Blackwood, D., & Muir, W. J. (2006) · Annals of Medicine · doi:10.1080/07853890600946500 · Cited by 51

A method for the generation of conditional gene repair mutations in mice

Dragatsis, I. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.e10 · Cited by 52

NTNG1 mutations are a rare cause of Rett syndrome

Archer, H. L., Evans, J., Millar, D. S., Thompson, P., Kerr, A., Leonard, H., Christodoulou, J., Ravine, D., Lazarou, L., Grove, L., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31133 · Cited by 52

Cerebrospinal fluid d-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients

Fuchs, S. A., de Barse, M. M. J., Scheepers, F. E., Cahn, W., DORLAND, L., der Velden, M. G. M. D. S., Klomp, L. W. J., Berger, R., Kahn, R. S., & de Koning, T. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.12.002 · Cited by 52

Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients

Rice, S. R., Niu, N., Berman, D., Heston, L. L., & Sobell, J. L. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000838 · Cited by 52

Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis

Wiescholleck, V., & Manahan‐Vaughan, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.001 · Cited by 54

The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons

Ehmsen, J. T., Liu, Y. U., Wang, Y., Paladugu, N., Johnson, A. E., Rothstein, J. D., du Lac, S., Mattson, M. P., & Höke, A. (2016) · Scientific Reports · doi:10.1038/srep35592 · Cited by 51

Effect of systemic administration of d-serine on the levels of d- and l-serine in several brain areas and periphery of rat

Hashimoto, A., & Chiba, Y. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.036 · Cited by 51

Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats

Tascedda, F., Blom, J. M. C., Brunello, N., Zolin, K., Gennarelli, M., Colzi, A., Bravi, D., Carra, S., Racagni, G., & Riva, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01135-0 · Cited by 51

Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia

Joo, A., Shibata, H., Ninomiya, H., Kawasaki, H., Tashiro, N., & Fukumaki, Y. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000841 · Cited by 51

Neurosurgery for schizophrenia: an update on pathophysiology and a novel therapeutic target

Mikell, C. B., Sinha, S. R., & Sheth, S. A. (2015) · Journal of neurosurgery · doi:10.3171/2015.4.jns15120 · Cited by 53

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1PAM VU6004256

Grannan, M. D., Mielnik, C. A., Moran, S. P., Gould, R. W., Ball, J., Lu, Z., Bubser, M., Ramsey, A. J., Abe, M., Cho, H. P., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00230 · Cited by 51

The distinct movement disorder in anti‐NMDA receptor encephalitis may be related to status dissociatus: A hypothesis

Stamelou, M., Plazzi, G., Lugaresi, E., Edwards, M. J., & Bhatia, K. P. (2012) · Movement Disorders · doi:10.1002/mds.25072 · Cited by 50

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice

Pogorelov, V. M., Rodriguiz, R. M., Cheng, J., Huang, M., Schmerberg, C. M., Meltzer, H. Y., Roth, B. L., Kozikowski, A. P., & Wetsel, W. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.52 · Cited by 52

Aggrecan Hypomorphism Compromises Articular Cartilage Biomechanical Properties and Is Associated with Increased Incidence of Spontaneous Osteoarthritis

Alberton, P., Dugonitsch, H. C., Hartmann, B., Li, P., Farkas, Z., Saller, M. M., Clausen‐Schaumann, H., & Aszódi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051008 · Cited by 50

Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs

Owen, D., & Matthews, S. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.122887 · Cited by 52

Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia

Goltsov, A. Y., Loseva, J. G., Андреева, Т. В., Grigorenko, A. P., Abramova, L. I., Каледа, В. Г., Александровна, О. В., Moliaka, Y. K., & Rogaev, E. I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001801 · Cited by 50

Protein tyrosine phosphatase alpha (PTPα) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety

Skelton, M. R., Ponniah, S., Wang, D. Z. ‐., Doetschman, T., Vorhees, C. V., & Pallen, C. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02839-7 · Cited by 50

Fyn Is Required for Haloperidol-induced Catalepsy in Mice

Hattori, K., Uchino, S., Isosaka, T., Maekawa, M., Iyo, M., Sato, T., Kohsaka, S., Yagi, T., & Yuasa, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511608200 · Cited by 50

Mechanisms Underlying Circuit Dysfunction in Neurodevelopmental Disorders

Exposito-Alonso, D., & Rico, B. (2022) · Annual Review of Genetics · doi:10.1146/annurev-genet-072820-023642 · Cited by 49

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F. W., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 162

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia

Ramsey, A. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17906-2 · Cited by 50

Mice lacking NR1 or NR2B protein die perinatally (For-

Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (2013)

The involvement of N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia

Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33

Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia

Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120